CNO Financial Group, Inc.: insider trades · United States · SEC (Form 4)

About CNO Financial Group, Inc.

CNO Financial Group, Inc. (NYSE: CNO) is a U.S.-listed insurance and financial services company headquartered in Carmel, Indiana, United States. For French-speaking investors, CNO is best understood as a specialty insurer focused on helping protect the financial future of middle-income Americans, especially pre-retirees and retirees. The company has built a multi-brand platform over time and today operates primarily through Bankers Life, Colonial Penn, Optavise, and Washington National, giving it exposure across several adjacent insurance and workforce-benefits niches. CNO’s business model is centered on life insurance, health insurance, annuities, financial services, and workforce benefits solutions. Rather than competing as a broad-based mass-market insurer, the group concentrates on customer segments where advice, product design, persistence, and distribution relationships matter. Its operating footprint is national in scope, with offices in more than 220 communities across the United States. That breadth matters commercially: CNO can support direct, agent-driven, and partner-based distribution while maintaining a strong local presence in its core markets. Each brand serves a distinct role. Bankers Life is positioned toward pre-retiree and retiree customers and is associated with life, health, annuity, and retirement-related offerings. Colonial Penn is widely recognized for consumer-oriented life insurance products. Optavise expands CNO’s worksite and employee-benefits capabilities, while Washington National adds capability in supplemental health, income protection, and related protection products. This brand architecture helps CNO address different customer needs without diluting its core specialty in middle-income protection. From a competitive standpoint, CNO is not trying to be the largest insurer in the United States. Its edge lies in specialization, distribution reach, and product relevance to a clearly defined demographic. The company also emphasizes capital discipline and balance-sheet strength, and it highlights investment-grade ratings from major agencies. For investors, the key analytical questions are the durability of sales momentum, underwriting discipline, sensitivity to interest rates and investment income, and the company’s ability to convert sales into sustainable profitability and shareholder returns. Recent developments have reinforced that profile. On February 5, 2026, CNO reported full-year 2025 results and said it exceeded most guidance metrics, with strong sales momentum and record annualized premium growth. On February 11, 2026, the board declared a quarterly dividend of $0.17 per share. The company also continued capital returns through share repurchases. These actions suggest management remains focused on earnings growth, capital efficiency, and shareholder remuneration. In market terms, CNO is an insurance name listed on the NYSE in the United States, offering targeted exposure to life, health, and retirement protection demand.